Genomic and Metabolomic Predictors of Success After Laparoscopic Ovarian Drilling in PCOS
Medisentra · 2023
DOI: 10.70945/m.v01i01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medisentra, 2023. Verfasst von Christian Delles und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Polycystic ovary syndrome (PCOS) demonstrates heterogeneous response to laparoscopic ovarian drilling, necessitating genomic–metabolomic biomarkers to predict ovulatory recovery and optimize individualized fertility outcomes in resistant anovulatory phenotypes.
Objective
To evaluate integrated genomic and metabolomic predictors of post-drilling ovulatory success, metabolic normalization, and conception potential among clomiphene-resistant PCOS patients using advanced multi-omic statistical modeling and pathway-based correlation analysis.
Methods
A prospective cohort of 176 women with clomiphene-resistant PCOS was studied at the University of Glasgow, UK (June 2022–June 2023). Genomic sequencing targeted 24 polymorphisms across FSHR, INSR, SIRT1, and CYP11A1 genes. LC–MS-based metabolomics quantified 86 circulating metabolites pre- and post-LOD. Ovulation, endocrine indices, and conception outcomes were correlated using multivariate regression (SPSS v26.0), with statistical significance defined at p < 0.05.
Results
Ovulatory restoration occurred in 132/176 patients (75.0 %), and conception within 12 months in 68 (38.6 %). Responders exhibited significantly lower baseline LH/FSH ratio (2.34 ± 0.81 vs 3.12 ± 0.97; *p = 0.004) and AMH (8.6 ± 2.3 vs 11.2 ± 3.0 ng/mL; *p = 0.012). SIRT1 (rs12778366) T-allele and FSHR (Ser680Asn) polymorphism predicted post-LOD ovulation (β = 0.58, p = 0.001; β = 0.42, p = 0.008). Metabolomic profiling identified elevated succinate (+41 %, p = 0.002), reduced leucine/isoleucine (–27 %, p = 0.011), and increased nicotinamide (+19 %, p = 0.018) in responders, reflecting enhanced mitochondrial oxidation and insulin sensitivity. The combined genomic–metabolomic model explained 83.2 % variance in ovulatory success (Adjusted R² = 0.832, p < 0.001), and predicted 41 % of metabolic improvement in HOMA-IR indices (Δ –2.21 ± 0.64, p < 0.001).
Conclusion
Integrative genomic–metabolomic analysis accurately predicts ovulatory and metabolic recovery after ovarian drilling. Personalized biomarker-based selection may optimize surgical indications and improve fertility and metabolic outcomes in heterogeneous PCOS populations.
Zitieren
APA
Delles, C., & Iredale, J. (2023). Genomic and Metabolomic Predictors of Success After Laparoscopic Ovarian Drilling in PCOS. Medisentra. https://doi.org/10.70945/m.v01i01.005
Vancouver
Delles C, Iredale J. Genomic and Metabolomic Predictors of Success After Laparoscopic Ovarian Drilling in PCOS. Medisentra. 2023. doi:10.70945/m.v01i01.005
BibTeX
@article{Delles2023,
author = {Delles, Christian and Iredale, John},
title = {Genomic and Metabolomic Predictors of Success After Laparoscopic Ovarian Drilling in PCOS},
journal = {Medisentra},
year = {2023},
doi = {10.70945/m.v01i01.005}
}
EUVIMED